Cargando…
In Vivo Modelling of Hepatitis B Virus Subgenotype A1 Replication Using Adeno-Associated Viral Vectors
The paucity of animal models that simulate the replication of the hepatitis B virus (HBV) is an impediment to advancing new anti-viral treatments. The work reported here employed recombinant adeno-associated viruses (AAVs) to model HBV subgenotype A1 and subgenotype D3 replication in vitro and in vi...
Autores principales: | Limani, Shonisani Wendy, Mnyandu, Njabulo, Ely, Abdullah, Wadee, Reubina, Kramvis, Anna, Arbuthnot, Patrick, Maepa, Mohube Betty |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8618177/ https://www.ncbi.nlm.nih.gov/pubmed/34835053 http://dx.doi.org/10.3390/v13112247 |
Ejemplares similares
-
Advances in designing Adeno-associated viral vectors for development of anti-HBV gene therapeutics
por: Mnyandu, Njabulo, et al.
Publicado: (2021) -
Advances with RNAi-Based Therapy for Hepatitis B Virus Infection
por: van den Berg, Fiona, et al.
Publicado: (2020) -
Sustained Inhibition of HBV Replication In Vivo after Systemic Injection of AAVs Encoding Artificial Antiviral Primary MicroRNAs
por: Maepa, Mohube Betty, et al.
Publicado: (2017) -
Gene Therapy for Chronic HBV—Can We Eliminate cccDNA?
por: Bloom, Kristie, et al.
Publicado: (2018) -
Recent Update on the Role of Circular RNAs in Hepatocellular Carcinoma
por: Ely, Abdullah, et al.
Publicado: (2021)